Pratima Prakash Gajakosh null, Pratima Prakash Gajakosh 1 null, S D Chauhan 2 null, V S Joshi 3 null, Sangita Agale 4 null
This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.
How to cite this article: Pratima Prakash Gajakosh, S D Chauhan, V S Joshi, et al.,/Comparative Study of Etomidate and Propofol for Induction of General Anesthesia/Indian J Anesth Analg. 2022;9(5)225-230.
Background and Objectives: Induction of anesthesia is a critical part of anesthesia practice. Sudden hypotension, arrhythmias, and cardiovascular collapse are threatening complications following injection of induction agent in hemodynamically unstable patients. Present prospective randomized study is designed to compare propofol and etomidate for their effect on hemodynamics in patients undergoing general anesthesia.
Methods: Hundred ASA I and II patients of age group 18-60 years scheduled for elective surgical procedure under general anesthesia were randomly divided into two groups of 50 each receiving propofol (2 mg/kg) and etomidate (0.3 mg/kg) as an induction agent. Vital parameters at induction, laryngoscopy and thereafter recorded for comparison.
Results: Demographic variables were comparable in both the groups. Patients in etomidate group showed little change in mean arterial pressure (MAP) and heart rate (HR) compared to propofol (p > 0.05) from baseline value.
Conclusions: This study concludes that etomidate is a better agent for induction than propofol in view of hemodynamic stability.
How to cite this article: Pratima Prakash Gajakosh, S D Chauhan, V S Joshi, et al.,/Comparative Study of Etomidate and Propofol for Induction of General Anesthesia/Indian J Anesth Analg. 2022;9(5)225-230.
This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.
| Received | Accepted | Published |
|---|---|---|
| June 29, 2022 | July 30, 2022 | October 20, 2022 |
Tuesday 14 July 2026, 09:01:48 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | June 29, 2022 |
| Accepted | July 30, 2022 |
| Published | October 20, 2022 |
This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.